Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc

Clinical trial NCT00289731 · COMPLETED

Trial details

NCT number: NCT00289731
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hepatitis B Hepatitis A

Start date: 2003-11-24
Primary completion: 2004-12-21
Enrollment: 596

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.